Jazz Pharmaceuticals’s CBD Trial Misses Primary Endpoint – MarketWatch Jazz Pharmaceuticals’s CBD Trial Misses Primary Endpoint MarketWatch Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest